All lobbying filings
CHAMBER HILL STRATEGIES
Lobbying for MARSHALL BIORESOURCES · commercial animal breeder
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
New York
Lobbyists on this filing
3
-
JENNIFER BELLPreviously held: Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
-
JENNIFER HOLLANDPreviously held: Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)
-
ZACHARY SCHULZPreviously held: Legislative Correspondent, Sen. Charles Grassley (R-IA)
Government bodies contacted
4
Lobbying activity
2
S. 5048/HR 7248, the FDA Modernization Act; issues related to pre-clinical research; HR 10522, the Companion Animal Protection Against Cruel Testing Act; HR 10532, the Beagle Liberation Act
HR 10523, the Prohibiting Unethical Procedures on Pets in Science Act; HR 10627, the Animal Welfare Enforcement Improvement Act
Bills named in this filing
6